Qiagen N.V. ( QGEN) - Key Metrics
QGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.59 | $0.50 | $0.97 | $0.76 |
| 2026Q1 | $2.38 | $0.33 | $0.49 | $0.26 |
| 2025Q4 | $2.60 | $0.52 | $0.91 | $0.56 |
| 2025Q3 | $2.46 | $0.60 | $0.76 | $0.55 |
| 2025Q2 | $2.46 | $0.44 | $0.75 | $0.56 |
QGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 19.55 |
| 2026Q1 | 696.69% | 30.33 |
| 2025Q4 | 0% | 22.76 |
| 2025Q3 | 41.71% | 18.62 |
| 2025Q2 | 0% | 27.31 |
QGEN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.96% | 0% |
| 2026Q1 | 0.65% | 5.72% |
| 2025Q4 | 1.19% | 0% |
| 2025Q3 | 1.23% | 0.56% |
| 2025Q2 | 1.16% | 0% |
QGEN
Price: $43.47
Dividend Yield: 0.83%
Forward Dividend Yield: 0.81%
Payout Ratio: 377.03%
Dividend Per Share: 0.35 USD
Earnings Per Share: 1.91 USD
P/E Ratio: 22.33
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: Netherlands
Volume: 670300
Ebitda: 103.6 millionMarket Capitalization: 8.8 billion
Average Dividend Frequency: 1
Years Paying Dividends: 3